...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BIO-Europe Presentation
Reply New Message
Back To Forum List View
Icon president BIO-Europe Presentation
5
BearDownAZ
Mar 13, 2018 12:09PM
Icon president Re: BIO-Europe Presentation
6
BearDownAZ
Mar 13, 2018 04:05PM

Previous presentations have a slide up front titled "Share Structure Profile" that lists the Enterprise Value Estimate (eg for the last one: $350 to $375MM USD, $2.50 to $3.00 USD/share).

For this presentation, that's been replaced with a slide titled "Zenith Profile" does not list the Enterprise Value Estimate.

3 Recommendations
Icon president Re: BIO-Europe Presentation
5
BearDownAZ
Mar 21, 2018 11:37AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply